<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0193600</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-43861</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Nephrology</subject><subj-group><subject>Kidney stones</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Urology</subject><subj-group><subject>Kidney stones</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Cohort studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug research and development</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal system</subject><subj-group><subject>Ureter</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Renal system</subject><subj-group><subject>Ureter</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Science policy</subject><subj-group><subject>Research integrity</subject><subj-group><subject>Publication ethics</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research facilities</subject><subj-group><subject>Information centers</subject><subj-group><subject>Libraries</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Use of the ureteral access sheath during ureteroscopy: A systematic review and meta-analysis</article-title>
<alt-title alt-title-type="running-head">Ureteral access sheath and ureteroscopy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Jian</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Zhao</surname>
<given-names>Zhijian</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>AlSmadi</surname>
<given-names>Jad Khaled</given-names>
</name>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liang</surname>
<given-names>Xiongfa</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zhong</surname>
<given-names>Fangling</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zeng</surname>
<given-names>Tao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Weizhou</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Deng</surname>
<given-names>Tuo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lai</surname>
<given-names>Yongchang</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liu</surname>
<given-names>Luhao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zeng</surname>
<given-names>Guohua</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3923-3093</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Wenqi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Urology, Minimally Invasive Surgery center, Guangzhou Institute of Urology, Guangdong Key Laboratory of Urology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of organ transplantation, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Gao</surname>
<given-names>Xin</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Sun Yat-sen University, CHINA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">wwqwml@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>2</issue>
<elocation-id>e0193600</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>12</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Huang et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0193600"/>
<abstract>
<p>The debate still rages on for the usefulness of ureteral access sheath (UAS). Therefore, a meta-analysis to discuss the effects of applying UAS during ureteroscopy was performed. The protocol for the review is available on PROSPERO (CRD42017052327). A literature search was conducted up to November, 2017 using the Web of science, PUBMED, EMBASE and Cochrane Library. The quality of articles was assessed by the Jadad scale and Newcastle Ottawa Scale (NOS). Egger’s test and the trim-and-fill method were used to evaluate publication bias. Effect sizes were calculated by pooled odds ratio (ORs) and mean differences (MDs). Sensitivity analyses and subgroup analyses were performed to explore the origin of heterogeneity. Eight trials with a total of 3099 patients and 3127 procedures were identified. Results showed no significant difference in stone-free rate (SFR) (OR = 0.83, 95% CI 0.52–1.33, P = 0.45), intraoperative complications (OR = 1.16, 95% CI 0.81–7.69, P = 0.88), operative time (MD = 4.09, 95% CI -15.08–23.26, P = 0.68) and hospitalization duration (MD = -0.13, 95% CI -0.32–0.06, P = 0.18). However, the incidence of postoperative complications was higher in UAS group (OR = 1.46, 95% CI 1.06–2.00, P = 0.02). Evidence from meta-analysis indicated that the use of UAS during ureteroscopy did not manifest advantages. However, given the intrinsic restrictions of the quality of selected articles, more randomized controlled trials (RCTs) are warranted to update the findings of this analysis.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>The National Natural Science Foundation of China</institution>
</funding-source>
<award-id>81570633</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3923-3093</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Wenqi</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Science and Technology Planning Project of Guangzhou City, China</institution>
</funding-source>
<award-id>201604020001</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3923-3093</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Wenqi</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution>Science and Technology Planning Project of Guangzhou City, China</institution>
</funding-source>
<award-id>201607010359</award-id>
</award-group>
<award-group id="award004">
<funding-source>
<institution>General Guide Project of Guangzhou City Bureau of Education</institution>
</funding-source>
<award-id>1201410963</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3923-3093</contrib-id>
<name name-style="western">
<surname>Wu</surname>
<given-names>Wenqi</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was financed by The National Natural Science Foundation of China (No.81570633); Science and Technology Planning Project of Guangzhou City, China (No.201604020001, 201607010359) and General Guide Project of Guangzhou City Bureau of Education (No.1201410963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<page-count count="12"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Ureteral access sheath (UAS) was first introduced in 1974 to facilitate passing ureteroscope into the ureter [<xref ref-type="bibr" rid="pone.0193600.ref001">1</xref>]. With the progress of technology, hydrophilic coating of UAS minimized shear force and enabled smoother passage of the sheath into the ureter, hub-locking mechanism enabled the sheath and the dilator to be passed through the ureter as a whole one unit. Those modifications have increased the safety and wide use of UAS [<xref ref-type="bibr" rid="pone.0193600.ref002">2</xref>]. Theoretically, it provides an access to the collecting system with the ability for multiple entries and exits of the ureter, allowing for evaluating any portion of the kidney, decreasing intrarenal pressure during irrigation, and improving drainage around the scope and visibility, thus protecting the scope when performing lithotripsy and extracting stone fragments [<xref ref-type="bibr" rid="pone.0193600.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0193600.ref006">6</xref>]. Nevertheless, there have been some misgivings concerning UAS use and the risk of ureteral injury [<xref ref-type="bibr" rid="pone.0193600.ref007">7</xref>]. Whether the UAS is an efficacious equipment remains hang in the wind and the debate rages on. Several studies on this issue had been conducted, while the results were contradictory [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>]. Here, we performed a systematic review and meta-analysis based on current evidence to assess the effectiveness and safety of the use of ureteral access sheath during ureteroscopy, in aim to conclude an evidence-based recommendation for clinical practice.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec003">
<title>Search strategy</title>
<p>This systematic review and meta-analysis was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement. The protocol for the review was available on PROSPERO (CRD42017052327; <ext-link ext-link-type="uri" xlink:href="https://www.crd.york.ac.uk/prospero/" xlink:type="simple">https://www.crd.york.ac.uk/prospero/</ext-link>). Literature retrieval was conducted up to November, 2017 using Web of science, PUBMED, EMBASE and Cochrane Library. The following Medical Subject Heading (MeSH) or Emtree terms combined free terms of “ureteroscopy” and “ureteral access sheath” were searched in different databases. The methodology filters about study design was derived from the Francis A. Countway Library of Medicine (<ext-link ext-link-type="uri" xlink:href="http://guides.library.harvard.edu/meta-analysis" xlink:type="simple">http://guides.library.harvard.edu/meta-analysis</ext-link>). Additionally, we performed a manual search from references of included articles to retrieve other applicable studies. There were no language or publication date restriction in retrieval strategy.</p>
</sec>
<sec id="sec004">
<title>Selection criteria</title>
<p>All processes including literature search, selection criteria, data extraction, quality assessments, and statistical analyses were performed by two authors independently and double-checked by both. Any divergence was disposed by a senior author. Eligibility criteria for the included studies were defined base on the PICOS principles: (1) Participants (P): Patients were diagnosed or treated by ureteroscopy. (2) Interventions (I) and comparisons (C): Exploring the effect of UAS during ureteroscopy. (3) Outcomes (O): Including at least one of the following outcomes: stone-free rate (SFR), intraoperative or postoperative complications, operative time and the hospitalization time. (4) Study design (S): RCTs or comparative studies with the relative data could be used directly or indirectly. Articles met the following points were abandoned: (1) Letters, review articles, laboratory studies, case reports and animal experimental studies. (2) Absence of key information such as sample size, 95% CI, and P value or this value could not be calculated. (3) The study design without a comparative group. (4) A repetitive publication article.</p>
</sec>
<sec id="sec005">
<title>Data extraction</title>
<p>The relevant data of included studies were extracted with a well-designed form. Data collectors were blinded to authors or journals. The following data were extracted from each article independently: sample sizes, procedures performed, study period, country, follow-up time, article type, age, stone burden, preoperative or postoperative stent, outcomes and so on. The collecting data were gathered with the primitive form from article to insure the veracity. Only the optimal research design and the most holonomic data included when a repeated article was met. We contacted the original authors to obtain more detail information when necessary. The primary outcome was SFR. The secondary outcomes included intraoperative and postoperative complications, operative time and hospital stay.</p>
</sec>
<sec id="sec006">
<title>Quality assessments</title>
<p>The quality of RCTs were assessed with Jadad scale [<xref ref-type="bibr" rid="pone.0193600.ref016">16</xref>]. A 9-score system named Newcastle Ottawa Scale (NOS) [<xref ref-type="bibr" rid="pone.0193600.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0193600.ref018">18</xref>] was used when non randomized controlled trials (non-RCTs) were met. Studies estimated with this system were considered of high-quality if achieved a score of seven or more.</p>
</sec>
<sec id="sec007">
<title>Statistical analysis</title>
<p>The relevant data were analyzed by Review Manager Version 5.3 software (Review Manager, Version 5.3 for Windows, The Cochrane Collaboration, 2013) and STATA 12.0 (StataCorp, College Station, TX, USA). Pooled odds ratios (ORs) and mean differences (MDs) were respectively calculated as the summary statistic for dichotomous variables and continuous variables with 95% confidence intervals (CIs). The Z test was used to analyze pooled effects, and a P-value of less than 0.05 was considered statistically significant. The standard deviation (SD) was converted by sample size and range using the theory described by Hozo et al if necessary [<xref ref-type="bibr" rid="pone.0193600.ref019">19</xref>]. Heterogeneity was appraised using Cochran’s Q test (reported with a x<sup>2</sup>-value and P-value) and I<sup>2</sup> statistic [<xref ref-type="bibr" rid="pone.0193600.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0193600.ref021">21</xref>]. A P-value of less than 0.1 means the presence of heterogeneity when the Q test was performed. An I<sup>2</sup> value of more than 50% was considered an indication for moderate to serious heterogeneity. Reasons for statistical heterogeneity were explored with sensitivity analyses. Sensitivity analyses were conducted by exclusion of individual studies. A random-effects model was used for pooling when there was evidence of heterogeneity [<xref ref-type="bibr" rid="pone.0193600.ref022">22</xref>]. Otherwise, the combined estimates were shown with a fixed-effects model [<xref ref-type="bibr" rid="pone.0193600.ref023">23</xref>]. Subgroup analyses were performed according to patient age, stone site, study design, the control of stone size, and the bias from semirigid ureteroscopy to evaluate UAS and non-UAS groups. The Egger linear regression test [<xref ref-type="bibr" rid="pone.0193600.ref024">24</xref>] and the non-parametric trim-and-fill method [<xref ref-type="bibr" rid="pone.0193600.ref025">25</xref>] were conducted to explore the publication bias for SFR.</p>
</sec>
</sec>
<sec id="sec008" sec-type="results">
<title>Results</title>
<sec id="sec009">
<title>Literature search</title>
<p>The whole process of literature search was presented in <xref ref-type="fig" rid="pone.0193600.g001">Fig 1</xref>. The initial search identified 311 potentially relevant studies. Additionally, two studies were available by manual search with references. Then 142 duplicates were distinguished and excluded by the “duplicates check” function of NoteExpress. After the exclusion of case reports, non-comparative studies, reviews, in-vitro model studies and irrelevant-topic studies with the first browse of title and abstract, the full-text versions of 11 papers were identified to determine eligibility. In these articles, two studies were recognized as irrelevant topics, one of them was associated with an in-vitro model. Finally, eight eligible studies [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>] including 3099 patients, a total of 3127 procedures of which 1994 procedures for UAS group and 1133 procedures for non-UAS group, fulfilling the inclusion criteria were recognized.</p>
<fig id="pone.0193600.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193600.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of studies selection process.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec010">
<title>Study characteristics and quality assessment</title>
<p>Included trials were published between 2001 and 2016, and conducted in the United States (3), Switzerland (1), Greece (1), France (2), and England (1). The sample sizes ranged from 28 to 2239. Among the 8 included studies, there were 2 RCTs [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>] between UAS group and non-UAS group. Two studies belong to prospective cohort studies [<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>], four studies were classified to be retrospective cohort studies [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193600.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>]. The quality of included non-randomized studies were granted a score between 5 and 7. Both of RCTs got 2 scores on the Jadad scale (<xref ref-type="table" rid="pone.0193600.t001">Table 1</xref>). One of the included studies was related to pediatric stone management [<xref ref-type="bibr" rid="pone.0193600.ref012">12</xref>] and three of them were involved in distal ureteral abnormalities [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref012">12</xref>].</p>
<table-wrap id="pone.0193600.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193600.t001</object-id>
<label>Table 1</label> <caption><title>UAS versus non-UAS: Summary of selected studies.</title></caption>
<alternatives>
<graphic id="pone.0193600.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Reference</th>
<th align="left">Sample sizes/procedures performed, n</th>
<th align="left">Study period</th>
<th align="left">Country</th>
<th align="left">Follow-up time</th>
<th align="left">Article type</th>
<th align="left">Quality score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Kourambas 2001</td>
<td align="left">59/62</td>
<td align="left">Oct. 1999-Jan. 2000</td>
<td align="left">United States</td>
<td align="left">3 month</td>
<td align="left">RCT</td>
<td align="left">2<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left">De Sio 2004</td>
<td align="left">28</td>
<td align="left">1999 to May 2003</td>
<td align="left">Switzerland</td>
<td align="left">NR</td>
<td align="left">Retrospective cohort study</td>
<td align="left">5<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">L'esperance 2005</td>
<td align="left">256</td>
<td align="left">1997 to 2003</td>
<td align="left">United States</td>
<td align="left">2 month</td>
<td align="left">Retrospective cohort study</td>
<td align="left">7<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Pardalidis 2006</td>
<td align="left">98</td>
<td align="left">Jan. 2001 to Dec. 2004</td>
<td align="left">Greece</td>
<td align="left">1 year</td>
<td align="left">RCT</td>
<td align="left">2<xref ref-type="table-fn" rid="t001fn003"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left">Wang 2011</td>
<td align="left">96</td>
<td align="left">1999 to 2009</td>
<td align="left">United States</td>
<td align="left">11 month (0.2-110month)</td>
<td align="left">Retrospective cohort study</td>
<td align="left">5<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Berquet 2014</td>
<td align="left">280</td>
<td align="left">2009 to 2012</td>
<td align="left">France</td>
<td align="left">1–3 month</td>
<td align="left">Retrospective cohort study</td>
<td align="left">7<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Traxer 2015</td>
<td align="left">2239</td>
<td align="left">Jan. 2010 to Oct. 2012</td>
<td align="left">France</td>
<td align="left">NR</td>
<td align="left">Prospective cohort study</td>
<td align="left">5<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Geraghty 2016</td>
<td align="left">43/68</td>
<td align="left">Mar. 2012 to Oct. 2014</td>
<td align="left">England</td>
<td align="left">2–3 month</td>
<td align="left">Prospective cohort study</td>
<td align="left">6<xref ref-type="table-fn" rid="t001fn002"><sup>a</sup></xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>RCT randomized controlled trials, NR not reported.</p></fn>
<fn id="t001fn002"><p><sup>a</sup> Using Newcastle-Ottawa Scale (score from 0 to 9).</p></fn>
<fn id="t001fn003"><p><sup>b</sup> Using Jadad scale (score from 0 to 5).</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The baseline characteristics of the relevant literatures were indicated in <xref ref-type="table" rid="pone.0193600.t002">Table 2</xref>. The adjusted variables were recorded to develop a better understanding of the comparability between groups. A very important parameter, stone burden, was no significant differences in 6 original documents [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>].</p>
<table-wrap id="pone.0193600.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193600.t002</object-id>
<label>Table 2</label> <caption><title>Characteristics of selected studies.</title></caption>
<alternatives>
<graphic id="pone.0193600.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" style="background-color:#FFFFFF">Reference</th>
<th align="left" style="background-color:#FFFFFF">Group</th>
<th align="left" style="background-color:#FFFFFF">Procedures, n</th>
<th align="left" style="background-color:#FFFFFF">Age, years</th>
<th align="left" style="background-color:#FFFFFF">Stone burden, mm</th>
<th align="left" style="background-color:#FFFFFF">Preoperative stent, procedures, n (%)</th>
<th align="left" style="background-color:#FFFFFF">Postoperative stent, procedures, n(%)</th>
<th align="left" style="background-color:#FFFFFF">Flexible or semirigid ureteroscopy, F:S</th>
<th align="left" style="background-color:#FFFFFF">The definition of SFR</th>
<th align="left" style="background-color:#FFFFFF">Adjusted variable</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Kourambas 2001</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">30</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">43.8 (21–85)</td>
<td align="left" style="background-color:#FFFFFF">13.00</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" style="background-color:#FFFFFF">15</td>
<td align="left" style="background-color:#FFFFFF">25:5</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Stone burden, the use of flexible or semirigid ureteroscopy, fragmentation device</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">32</td>
<td align="left" style="background-color:#FFFFFF">10.35</td>
<td align="left" style="background-color:#FFFFFF">19</td>
<td align="left" style="background-color:#FFFFFF">23:9</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">De Sio 2004</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">12</td>
<td align="left" style="background-color:#FFFFFF">54 (26–71) and 61 (54–68)</td>
<td align="left" style="background-color:#FFFFFF">1.4 (1–2.5) and 0.7 (0.4–0.9)</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Semirigid ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">16</td>
<td align="left" style="background-color:#FFFFFF">45 (18–74) and 63 (61–75)</td>
<td align="left" style="background-color:#FFFFFF">1.6 (1.1–2.8) and 0.9 (0.4–1.2)</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">L'esperance 2005</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">173</td>
<td align="left" style="background-color:#FFFFFF">49</td>
<td align="left" style="background-color:#FFFFFF">8.7</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">77%</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Completely clean</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Age, gender, stone burden, stone location, postoperative stent</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">83</td>
<td align="left" style="background-color:#FFFFFF">47</td>
<td align="left" style="background-color:#FFFFFF">7.3</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Pardalidis 2006</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">48</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">48.5 (18–73)</td>
<td align="left" style="background-color:#FFFFFF">7.1</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">100%</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Completely clean</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Stone burden, Use of EHL</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">50</td>
<td align="left" style="background-color:#FFFFFF">7.8</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Wang 2011</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">40</td>
<td align="left" style="background-color:#FFFFFF">13.6±4.2 (4.0–20.9)</td>
<td align="left" style="background-color:#FFFFFF">12.5 ± 9.7 (3.0–54.0)</td>
<td align="left" style="background-color:#FFFFFF">12</td>
<td align="left" style="background-color:#FFFFFF">38</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">NR</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Age, BMI, gender, race, urinary tract abnormalities, preoperative stent</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">56</td>
<td align="left" style="background-color:#FFFFFF">12.7±4.6 (1.5–19.9)</td>
<td align="left" style="background-color:#FFFFFF">7.6 ±4.5 (0.8–27.0)</td>
<td align="left" style="background-color:#FFFFFF">14</td>
<td align="left" style="background-color:#FFFFFF">37</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Berquet 2014</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">157</td>
<td align="left" style="background-color:#FFFFFF">50±15.2</td>
<td align="left" style="background-color:#FFFFFF">15.15±9.8</td>
<td align="left" style="background-color:#FFFFFF">39 (24%)</td>
<td align="left" style="background-color:#FFFFFF">134 (85%)</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Residual stone ≦3mm</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Age, stone number, stone burden, postoperative stent</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">123</td>
<td align="left" style="background-color:#FFFFFF">52±17.3</td>
<td align="left" style="background-color:#FFFFFF">13.75±8.0</td>
<td align="left" style="background-color:#FFFFFF">62 (50%)</td>
<td align="left" style="background-color:#FFFFFF">94 (76%)</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Traxer 2015</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">1494</td>
<td align="left" style="background-color:#FFFFFF">51.2±14.98</td>
<td align="left" style="background-color:#FFFFFF">108.3±114.4<xref ref-type="table-fn" rid="t002fn003"><sup>a</sup></xref></td>
<td align="left" style="background-color:#FFFFFF">511</td>
<td align="left" style="background-color:#FFFFFF">1352</td>
<td align="left" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Residual stone ≦1mm</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Age, gender, BMI, renal congenital abnormality, stone burden, previous calculus treatment, solitary kidney, preoperative stent, case volume</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Non-UAS</td>
<td align="left" style="background-color:#FFFFFF">745</td>
<td align="left" style="background-color:#FFFFFF">50.2±14.95</td>
<td align="left" style="background-color:#FFFFFF">99.2±100.5<xref ref-type="table-fn" rid="t002fn003"><sup>a</sup></xref></td>
<td align="left" style="background-color:#FFFFFF">278</td>
<td align="left" style="background-color:#FFFFFF">611</td>
<td align="left" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
</tr>
<tr>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Geraghty 2016</td>
<td align="left" style="background-color:#FFFFFF">UAS</td>
<td align="left" style="background-color:#FFFFFF">40</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">54 (7–84)</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">29.2 (20–60)</td>
<td align="left" style="background-color:#FFFFFF">15</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">64 (94.1%)</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Flexible ureteroscopy</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Residual stone ≦2mm</td>
<td align="left" rowspan="2" style="background-color:#FFFFFF">Stone burden</td>
</tr>
<tr>
<td align="left">Non-UAS</td>
<td align="left">28</td>
<td align="left">11</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>NR not reported, SFR stone free rate, UAS ureteral access sheath, non-UAS without an ureteral access sheath, BMI Body Mass Index, F:S Flexible ureteroscopy: Semirigid ureteroscopy, EHL electrohydraulic lithotripsy, SD standard deviation.</p></fn>
<fn id="t002fn002"><p>Values are given as mean ± SD (range).</p></fn>
<fn id="t002fn003"><p><sup>a</sup> Stone burden was calculated as the sum of all stone sizes (length × width × 0.25 × 3.14159).</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec011">
<title>Primary outcomes</title>
<sec id="sec012">
<title>SFR</title>
<p>The definition of SFR was made in five studies [<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>]. There were two studies [<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>] identified SFR as having none of the stone left. One of the article [<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>] recognized it as residual stone less than 1 mm, while one [<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>] defined it as having a residual stone fragment that is less than 2 mm, and the other one [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>] described it as residual stone less than 3 mm. Computed Tomography scan and X-ray were the principal imaging examination to evaluate the residual stone. All studies have compared the difference of SFR between the UAS and non-UAS groups. The data of each articles were summarized with a random effects model and showed no significant difference between arms (OR = 0.83, 95% CI 0.52–1.33, P = 0.45, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2A</xref>). This result showed moderate heterogeneity (Q = 16.49, P = 0.02, I<sup>2</sup> = 58%, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2A</xref>). Sensitivity analysis by removing individual studies showed clinical heterogeneity of being due to the article of L’esperance et al [<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>]. Combining results of the remaining 7 studies with fixed effects model demonstrated a higher SFR for the non-UAS group rather than the UAS group (OR = 0.62, 95% CI 0.50–0.75, P &lt; 0.00001, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2B</xref>) and revealed no heterogeneity between groups (Q = 4.72, P = 0.58, I<sup>2</sup> = 0%, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2B</xref>).</p>
<fig id="pone.0193600.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193600.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plot in meta-analysis.</title>
<p>a SFR, b SFR with sensitivity analysis, c intraoperative complications, d postoperative complications, e operative time, f hospitalization time. UAS: ureteral access sheath; non-UAS: without an ureteral access sheath.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec013">
<title>Subgroup analysis</title>
<p>Subgroup analyses were conducted on account of age, diseased region, study design, the control of stone size, and the use of semirigid ureteroscopy to further estimate the efficiency of UAS in SFR. However, only the sort of prospective cohort study [<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>] in the subgroup analysis of study designs presented the different result with the original outcome, which was favoured of non-UAS group (OR = 0.59, 95% CI 0.47–0.74, P &lt; 0.00001; Q = 0.18, P = 0.68, I<sup>2</sup> = 0%, <xref ref-type="table" rid="pone.0193600.t003">Table 3</xref>).</p>
<table-wrap id="pone.0193600.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0193600.t003</object-id>
<label>Table 3</label> <caption><title>Subgroup analysis.</title></caption>
<alternatives>
<graphic id="pone.0193600.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2" style="background-color:#FFFFFF">subgroup</th>
<th align="left" rowspan="2" style="background-color:#FFFFFF">Studies, n</th>
<th align="left" colspan="3" style="background-color:#FFFFFF">Heterogeneity</th>
<th align="left" rowspan="2" style="background-color:#FFFFFF">OR (95% CI)</th>
<th align="left" rowspan="2" style="background-color:#FFFFFF">P value</th>
</tr>
<tr>
<th align="left" style="background-color:#FFFFFF">Q</th>
<th align="left" style="background-color:#FFFFFF">P value</th>
<th align="left" style="background-color:#FFFFFF">I<sup>2</sup>, %</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="7" style="background-color:#FFFFFF">Age</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Adult</td>
<td align="left" style="background-color:#FFFFFF">7</td>
<td align="left" style="background-color:#FFFFFF">15.50</td>
<td align="left" style="background-color:#FFFFFF">0.02</td>
<td align="left" style="background-color:#FFFFFF">61</td>
<td align="left" style="background-color:#FFFFFF">0.92 (0.55–1.54)</td>
<td align="left" style="background-color:#FFFFFF">0.74</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Children</td>
<td align="left" style="background-color:#FFFFFF">1</td>
<td align="left" style="background-color:#FFFFFF">-</td>
<td align="left" style="background-color:#FFFFFF">-</td>
<td align="left" style="background-color:#FFFFFF">-</td>
<td align="left" style="background-color:#FFFFFF">0.41 (0.14–1.17)</td>
<td align="left" style="background-color:#FFFFFF">0.10</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#FFFFFF">Diseased region</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Proximal</td>
<td align="left" style="background-color:#FFFFFF">5</td>
<td align="left" style="background-color:#FFFFFF">13.22</td>
<td align="left" style="background-color:#FFFFFF">0.01</td>
<td align="left" style="background-color:#FFFFFF">70</td>
<td align="left" style="background-color:#FFFFFF">0.90 (0.52–1.56)</td>
<td align="left" style="background-color:#FFFFFF">0.72</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Distal</td>
<td align="left" style="background-color:#FFFFFF">3</td>
<td align="left" style="background-color:#FFFFFF">3.04</td>
<td align="left" style="background-color:#FFFFFF">0.22</td>
<td align="left" style="background-color:#FFFFFF">34</td>
<td align="left" style="background-color:#FFFFFF">0.62 (0.18–2.16)</td>
<td align="left" style="background-color:#FFFFFF">0.45</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#FFFFFF">Study design</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">RCT</td>
<td align="left" style="background-color:#FFFFFF">2</td>
<td align="left" style="background-color:#FFFFFF">0.68</td>
<td align="left" style="background-color:#FFFFFF">0.41</td>
<td align="left" style="background-color:#FFFFFF">0</td>
<td align="left" style="background-color:#FFFFFF">0.60 (0.18–1.99)</td>
<td align="left" style="background-color:#FFFFFF">0.40</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Prospective cohort study</td>
<td align="left" style="background-color:#FFFFFF">2</td>
<td align="left" style="background-color:#FFFFFF">0.18</td>
<td align="left" style="background-color:#FFFFFF">0.68</td>
<td align="left" style="background-color:#FFFFFF">0</td>
<td align="left" style="background-color:#FFFFFF">0.59 (0.47–0.74)</td>
<td align="left" style="background-color:#FFFFFF">&lt;0.00001</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Retrospective cohort study</td>
<td align="left" style="background-color:#FFFFFF">4</td>
<td align="left" style="background-color:#FFFFFF">7.05</td>
<td align="left" style="background-color:#FFFFFF">0.07</td>
<td align="left" style="background-color:#FFFFFF">57</td>
<td align="left" style="background-color:#FFFFFF">1.08 (0.54–2.14)</td>
<td align="left" style="background-color:#FFFFFF">0.84</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#FFFFFF">The control of stone burden</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Control</td>
<td align="left" style="background-color:#FFFFFF">6</td>
<td align="left" style="background-color:#FFFFFF">13.96</td>
<td align="left" style="background-color:#FFFFFF">0.02</td>
<td align="left" style="background-color:#FFFFFF">64</td>
<td align="left" style="background-color:#FFFFFF">0.86 (0.51–1.47)</td>
<td align="left" style="background-color:#FFFFFF">0.59</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Uncontrolled</td>
<td align="left" style="background-color:#FFFFFF">2</td>
<td align="left" style="background-color:#FFFFFF">2.49</td>
<td align="left" style="background-color:#FFFFFF">0.11</td>
<td align="left" style="background-color:#FFFFFF">60</td>
<td align="left" style="background-color:#FFFFFF">0.81 (0.16–4.18)</td>
<td align="left" style="background-color:#FFFFFF">0.80</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#FFFFFF">Extract/shatter stone with flexible or semirigid Ureteroscopy</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Flexible</td>
<td align="left" style="background-color:#FFFFFF">5</td>
<td align="left" style="background-color:#FFFFFF">13.95</td>
<td align="left" style="background-color:#FFFFFF">0.007</td>
<td align="left" style="background-color:#FFFFFF">71</td>
<td align="left" style="background-color:#FFFFFF">0.88 (0.48–1.61)</td>
<td align="left" style="background-color:#FFFFFF">0.68</td>
</tr>
<tr>
<td align="left" style="background-color:#FFFFFF">Semirigid</td>
<td align="left" style="background-color:#FFFFFF">3</td>
<td align="left" style="background-color:#FFFFFF">2.53</td>
<td align="left" style="background-color:#FFFFFF">0.28</td>
<td align="left" style="background-color:#FFFFFF">21</td>
<td align="left" style="background-color:#FFFFFF">0.70 (0.29–1.65)</td>
<td align="left" style="background-color:#FFFFFF">0.41</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>OR odds ratio, RCT randomized controlled trials.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Publication bias</title>
<p>Base on the SFR, there was no evidence of significant publication bias from the Egger test (t = 0.77, P = 0.47). A well-proportioned funnel plot was formed in a sensitivity analysis using the trim-and-fill method. After the performance of trim-and-fill method, we observed the OR was 0.78 (95% CI = 0.49–1.23, P = 0.28), which indicated the result of trim-and-fill method didn’t convert comparatively.</p>
</sec>
</sec>
<sec id="sec015">
<title>Secondary outcomes</title>
<sec id="sec016">
<title>Intraoperative complications</title>
<p>The intraoperative complications comprising bleeding, perforation and avulsion etc. Analyzing the data of 3 studies [<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>] with random effects model, including 2428 procedures, yielded no significant difference between case and control groups in terms of intraoperative complications (OR = 1.16, 95% CI 0.81–7.69, P = 0.88, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2C</xref>) with a moderate heterogeneity among trials (Q = 6.53, P = 0.04, I<sup>2</sup> = 69%, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2C</xref>).</p>
</sec>
<sec id="sec017">
<title>Postoperative complications</title>
<p>There were 6 articles [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>] providing data with regard to postoperative complications such as bleeding, fever, urinary tract infection, bladder cramps, lung embolism, sepsis and so forth. However, two articles [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>] with no events should be excluded because they didn’t provide any indication of the direction and magnitude of the relative treatment effect. Combining the results of studies with a fixed-effects model produced an OR of 1.46 (95% CI 1.06–2.00, P = 0.02; Q = 2.61, P = 0.45, I<sup>2</sup> = 0%; <xref ref-type="fig" rid="pone.0193600.g002">Fig 2D</xref>), which comes into a conclusion that UAS group get a significant higher incidence of postoperative complications than non-UAS group.</p>
</sec>
<sec id="sec018">
<title>Operative time</title>
<p>Six studies mentioned the operative time [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>], whereas only 2 articles [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>] provided the SD. Only half of articles with lacking data provided the value of range [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>], which was essential to estimate SD with the theory of Hozo et al [<xref ref-type="bibr" rid="pone.0193600.ref019">19</xref>]. However, due to the limited sample size provided by De Sio et al [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>], it was excluded from the meta-analysis on this endpoint. Finally, three studies [<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>] including 2514 procedures were obtained and showed no significant difference between arms (MD = 4.09, 95% CI -15.08–23.26, P = 0.68, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2E</xref>) with a severe heterogeneity (Q = 71.48, P &lt; 0.00001, I<sup>2</sup> = 97%, <xref ref-type="fig" rid="pone.0193600.g002">Fig 2E</xref>).</p>
</sec>
<sec id="sec019">
<title>Hospitalization duration</title>
<p>There were only two articles that compared the difference between arms regarding hospitalization duration [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>]. Berquet et al [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>] demonstrated no significant difference between groups concerning this issue. Whereas, Traxer et al indicated that hospitalization periods were longer in cases treated without a UAS [<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>]. Pooling the data of these articles, meta-analysis for hospitalization duration showed no significant difference between groups (MD = -0.13, 95% CI -0.32–0.06, P = 0.18; Q = 1.47, P = 0.22, I<sup>2</sup> = 32%; <xref ref-type="fig" rid="pone.0193600.g002">Fig 2F</xref>).</p>
</sec>
</sec>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Discussion</title>
<p>Several articles had examined the effect of using UAS during ureteroscopy. However, the results of these studies were contradictory, even proposed completely different recommendations [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>]. To the best of our knowledge, this is the first meta-analysis to elaborate the relationship between those contradictions, which have pointed out an evidential orientation on this issue. Besides, it should be noted that a series of subgroup analyses such as age, diseased region, study design, the control of stone size and the use of semirigid ureteroscope have been conducted. Only the subgroup of study design revealed the different result with quondam one, which indicated the stability of this meta-analysis. Moreover, both of Egger test and trim-and-fill method indicated no publication bias in this meta-analysis.</p>
<p>The efficacy and safety of UAS during ureteroscopy with a systematic review and meta-analysis was evaluated. In general, 8 studies containing 3099 patients, a total of 3127 procedures were included. The results indicated the same effect on SFR, intraoperative complications, operative time and hospitalization duration but showed a significant increase in the incidence of postoperative complications in UAS arm.</p>
<p>Stone burden was no significant differences in 6 original documents [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0193600.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>]. Subgroup analysis of the control of stone burden showed the same with original result, which indicated the reliability of outcome of SFR. Proponents of UAS proposed that the use of UAS could serve to remove stone fragments with basket easily. Also, it provided a repeatable, safe and fast access to the upper urinary tract with improved vision [<xref ref-type="bibr" rid="pone.0193600.ref005">5</xref>]. Therefore, the potential superiority of UAS in the SFR has been advocated. However, Berquet et al [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>] documented the number of stone, stone location and the use of UAS had no effect on SFR. The only predictive factor of SFR was stone burden. Traxer et al [<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>] explored the effect of UAS with a sizable population of prospective study indicated that the SFR was 73.9% in UAS group versus 82.8% in non-UAS group, and presented that UAS is not used to increase SFR.</p>
<p>Some of the advantage of UAS have been recommended, such as providing an access to the collecting system with the ability for multiple entrie and exits of the ureter, decreasing intrarenal pressure during pulse or continuous ureteroscopic irrigation, and also improving drainage around the scope and visibility, thus protecting the scope when performing lithotripsy and extracting stone fragments [<xref ref-type="bibr" rid="pone.0193600.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0193600.ref006">6</xref>]. However, several articles have indicated that UAS could be responsible for postoperative complications such as persistent hematuria, ureteral stricture, urinary extravasation etc [<xref ref-type="bibr" rid="pone.0193600.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0193600.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0193600.ref026">26</xref>]. In this meta-analysis, the higher postoperative complication was observed in UAS group. Ureteral injury with UAS insertion resulting in more postoperative persistent hematuria, use of ureteral stents, post-operative pain, and even contributing to ureteral strictures [<xref ref-type="bibr" rid="pone.0193600.ref026">26</xref>,<xref ref-type="bibr" rid="pone.0193600.ref027">27</xref>]. Lallas et al [<xref ref-type="bibr" rid="pone.0193600.ref028">28</xref>] observed that nadir ureteral blood flow was 25%, 70%, and 80% below baseline when 10/12F, 12/14F, and 14/16F UAS were used during ureteroscopy, while the bigger size of UAS need more time to recover. Traxer et al [<xref ref-type="bibr" rid="pone.0193600.ref007">7</xref>] indicated that severe injury of ureteral smooth muscle layers is common even after a 12/14Fr UAS was inserted. Other studies [<xref ref-type="bibr" rid="pone.0193600.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0193600.ref029">29</xref>] also have shown that the insertion of the UAS could harm the ureteral mucosa and induce ischemia of the ureter. Furthermore, up-regulation of pro-inflammatory mediators, COX-2 and TNF-alpha were observed in the ureteral wall after the use of UAS, which might indicate another reason for postoperative pain and complications [<xref ref-type="bibr" rid="pone.0193600.ref030">30</xref>].</p>
<p>Among the studies for operative time, the synthesis of meta-analysis revealed the same effect between groups. Of note, with the estimation of SD from Pardalidis et al [<xref ref-type="bibr" rid="pone.0193600.ref011">11</xref>], it showed an inescapable deviation. Also, Kourambas et al [<xref ref-type="bibr" rid="pone.0193600.ref008">8</xref>] preferred the UAS group as they showed an advantage in operative time. On the other hand, Geraghty et al [<xref ref-type="bibr" rid="pone.0193600.ref015">15</xref>] and De Sio et al [<xref ref-type="bibr" rid="pone.0193600.ref009">9</xref>] demonstrated no significant difference between both arms. These results should not be neglected.</p>
<p>The following limitations were deserved mention in this meta-analysis. Firstly, this study was based on non-RCTs which meant the risk of bias from inappropriate random sequence generation and blinding was unavoidable. Secondly, several parameters indicated heterogeneity because of the discrepancy in study design, surgeon’s experience and some unmeasured confounders across studies. Finally, lack of the unified standard and the value of SD in some studies also prevented a more accurate analysis.</p>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Conclusions</title>
<p>To sum up, this is the first meta-analysis to evaluate the efficacy and safety of UAS during ureteroscopy and provides evidence that using a UAS in ureteroscopy neither has an effect on SFR, operative time, hospitalization time, nor intraoperative complications but significantly increases the incidence of postoperative complications. Current study didn’t manifest an obvious advantage for using a UAS during ureteroscopy, which indicated the use of UAS should not be a routine in all cases. However, given intrinsic restrictions of included studies, more RCTs are warranted to confirm and update the findings of this study.</p>
</sec>
<sec id="sec022">
<title>Supporting information</title>
<supplementary-material id="pone.0193600.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Egger test.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0193600.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Trim-and-fill method.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0193600.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.s003" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0193600.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.s004" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>The protocol from PROSPERO.</title>
<p>(CRD42017052327).</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0193600.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0193600.s005" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>The search strategy for PubMed.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank the data provided by the authors of included studies.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0193600.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takayasu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Aso</surname> <given-names>Y</given-names></name>. <article-title>Recent development for pyeloureteroscopy: guide tube method for its introduction into the ureter</article-title>. <source>J Urol</source>. <year>1974</year>;<volume>112</volume>(<issue>2</issue>):<fpage>176</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">4843325</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Monga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bhayani</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Landman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Conradie</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sundaram</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Clayman</surname> <given-names>RV</given-names></name>. <article-title>Ureteral access for upper urinary tract disease: the access sheath</article-title>. <source>J Endourol</source>. <year>2001</year>;<volume>15</volume>(<issue>8</issue>):<fpage>831</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/089277901753205843" xlink:type="simple">10.1089/089277901753205843</ext-link></comment> <object-id pub-id-type="pmid">11724124</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Breda</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ogunyemi</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Leppert</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Schulam</surname> <given-names>PG</given-names></name>. <article-title>Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones</article-title>. <source>Eur Urol</source>. <year>2009</year>;(<issue>5</issue>):<fpage>1190</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.eururo.2008.06.019" xlink:type="simple">10.1016/j.eururo.2008.06.019</ext-link></comment> <object-id pub-id-type="pmid">18571315</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanlangendonck</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Landman</surname> <given-names>J</given-names></name>. <article-title>Ureteral access strategies: pro-access sheath</article-title>. <source>Urol Clin North Am</source>. <year>2004</year>;<volume>31</volume>(<issue>1</issue>):<fpage>71</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0094-0143(03)00095-8" xlink:type="simple">10.1016/S0094-0143(03)00095-8</ext-link></comment> <object-id pub-id-type="pmid">15040403</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Breda</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Territo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>López-Martínez</surname> <given-names>JM</given-names></name>. <article-title>Benefits and risks of ureteral access sheaths for retrograde renal access</article-title>. <source>Curr Opin Urol</source>. <year>2016</year>;(<issue>1</issue>):<fpage>70</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MOU.0000000000000233" xlink:type="simple">10.1097/MOU.0000000000000233</ext-link></comment> <object-id pub-id-type="pmid">26555688</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rehman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Monga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Landman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>DI</given-names></name>, <name name-style="western"><surname>Felfela</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Conradie</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Characterization of intrapelvic pressure during ureteropyeloscopy with ureteral access sheaths</article-title>. <source>Urology</source>. <year>2003</year>;<volume>61</volume>(<issue>4</issue>):<fpage>713</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">12670551</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Traxer</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>A</given-names></name>. <article-title>Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery</article-title>. <source>J Urol</source>. <year>2013</year>;<volume>189</volume>(<issue>2</issue>):<fpage>580</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.juro.2012.08.197" xlink:type="simple">10.1016/j.juro.2012.08.197</ext-link></comment> <object-id pub-id-type="pmid">22982421</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kourambas</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Byrne</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Preminger</surname> <given-names>GM</given-names></name>. <article-title>Does a ureteral access sheath facilitate ureteroscopy?</article-title> <source>J Urol</source>. <year>2001</year>;<volume>165</volume>(<issue>3</issue>):<fpage>789</fpage>–<lpage>93</lpage>. <object-id pub-id-type="pmid">11176469</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Sio</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Autorino</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Damiano</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Oliva</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pane</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>D'Armiento</surname> <given-names>M</given-names></name>. <article-title>Expanding applications of the access sheath to ureterolithotripsy of distal ureteral stones. A frustrating experience</article-title>. <source>Urol Int</source>. <year>2004</year>;<volume>72</volume> <issue>Suppl 1</issue>:<fpage>55</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000076595" xlink:type="simple">10.1159/000076595</ext-link></comment> <object-id pub-id-type="pmid">15133337</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>L'esperance</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Ekeruo</surname> <given-names>WO</given-names></name>, <name name-style="western"><surname>Scales</surname> <given-names>CD</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Marguet</surname> <given-names>CG</given-names></name>, <name name-style="western"><surname>Springhart</surname> <given-names>WP</given-names></name>, <name name-style="western"><surname>Maloney</surname> <given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi</article-title>. <source>Urology</source>. <year>2005</year>;<volume>66</volume>(<issue>2</issue>):<fpage>252</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.urology.2005.03.019" xlink:type="simple">10.1016/j.urology.2005.03.019</ext-link></comment> <object-id pub-id-type="pmid">16040093</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pardalidis</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>Papatsoris</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Kapotis</surname> <given-names>CG</given-names></name>, <name name-style="western"><surname>Kosmaoglou</surname> <given-names>EV</given-names></name>. <article-title>Treatment of impacted lower third ureteral stones with the use of the ureteral access sheath</article-title>. <source>Urol Res</source>. <year>2006</year>;<volume>34</volume>(<issue>3</issue>):<fpage>211</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00240-006-0044-6" xlink:type="simple">10.1007/s00240-006-0044-6</ext-link></comment> <object-id pub-id-type="pmid">16477425</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>HH</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Routh</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Kokorowski</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Cilento</surname> <given-names>BG</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Nelson</surname> <given-names>CP</given-names></name>. <article-title>Use of the ureteral access sheath during ureteroscopy in children</article-title>. <source>J Urol</source>. <year>2011</year>;<volume>186</volume>(<issue>4 Suppl</issue>):<fpage>1728</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.juro.2011.03.072" xlink:type="simple">10.1016/j.juro.2011.03.072</ext-link></comment> <object-id pub-id-type="pmid">21855908</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berquet</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Prunel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Verhoest</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Mathieu</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bensalah</surname> <given-names>K</given-names></name>. <article-title>The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones</article-title>. <source>World J Urol</source>. <year>2014</year>;<volume>32</volume>(<issue>1</issue>):<fpage>229</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00345-013-1181-5" xlink:type="simple">10.1007/s00345-013-1181-5</ext-link></comment> <object-id pub-id-type="pmid">24166287</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Traxer</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Wendt-Nordahl</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sodha</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Rassweiler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Meretyk</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tefekli</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study</article-title>. <source>World J Urol</source>. <year>2015</year>;<volume>33</volume>(<issue>12</issue>):<fpage>2137</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00345-015-1582-8" xlink:type="simple">10.1007/s00345-015-1582-8</ext-link></comment> <object-id pub-id-type="pmid">25971204</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geraghty</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Ishii</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Somani</surname> <given-names>BK</given-names></name>. <article-title>Outcomes of flexible ureteroscopy and laser fragmentation for treatment of large renal stones with and without the use of ureteral access sheaths: Results from a university hospital with a review of literature</article-title>. <source>Scand J Urol</source>. <year>2016</year>;<volume>50</volume>(<issue>3</issue>):<fpage>216</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/21681805.2015.1121407" xlink:type="simple">10.3109/21681805.2015.1121407</ext-link></comment> <object-id pub-id-type="pmid">27111193</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Pham</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Jadad</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Moher</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</article-title> <source>Lancet</source>. <year>1998</year>;<volume>352</volume>(<issue>9128</issue>):<fpage>609</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(98)01085-X" xlink:type="simple">10.1016/S0140-6736(98)01085-X</ext-link></comment> <object-id pub-id-type="pmid">9746022</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name>. <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source>. <year>2010</year>;<volume>25</volume>(<issue>9</issue>):<fpage>603</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref018"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Wells GA, Shea B, O'Connell D, J Peterson, V Welch, M Losos, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link></mixed-citation></ref>
<ref id="pone.0193600.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hozo</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>Djulbegovic</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hozo</surname> <given-names>I</given-names></name>. <article-title>Estimating the mean and variance from the median, range, and the size of a sample</article-title>. <source>BMC Med Res Methodol</source>. <year>2005</year>;<day>20</day>;<volume>5</volume>:<fpage>13</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2288-5-13" xlink:type="simple">10.1186/1471-2288-5-13</ext-link></comment> <object-id pub-id-type="pmid">15840177</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>–<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/sim.1186" xlink:type="simple">10.1002/sim.1186</ext-link></comment> <object-id pub-id-type="pmid">12111919</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>. <year>2003</year>;<volume>327</volume>(<issue>7414</issue>):<fpage>557</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.327.7414.557" xlink:type="simple">10.1136/bmj.327.7414.557</ext-link></comment> <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname> <given-names>N</given-names></name>. <article-title>Meta-analysis in clinical trials revisited</article-title>. <source>Contemp Clin Trials</source>. <year>2015</year>;<volume>45</volume>(<issue>Pt A</issue>):<fpage>139</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cct.2015.09.002" xlink:type="simple">10.1016/j.cct.2015.09.002</ext-link></comment> <object-id pub-id-type="pmid">26343745</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woolf</surname> <given-names>B.</given-names></name> <article-title>On estimating the relation between blood group and disease</article-title>. <source>Ann Hum Genet</source>. <year>1955</year>;<volume>19</volume>(<issue>4</issue>):<fpage>251</fpage>–<lpage>3</lpage>. <object-id pub-id-type="pmid">14388528</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>(<issue>2</issue>):<fpage>455</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abrahams</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Stoller</surname> <given-names>ML</given-names></name>. <article-title>The argument against the routine use of ureteral access sheaths</article-title>. <source>Urol Clin North Am</source>. <year>2004</year>;<volume>31</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0094-0143(03)00085-5" xlink:type="simple">10.1016/S0094-0143(03)00085-5</ext-link></comment> <object-id pub-id-type="pmid">15040404</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rizkala</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>Monga</surname> <given-names>M</given-names></name>. <article-title>Controversies in ureteroscopy: wire, basket, and sheath</article-title>. <source>Indian J Urol</source>. <year>2013</year>;<volume>29</volume>(<issue>3</issue>):<fpage>244</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4103/0970-1591.117287" xlink:type="simple">10.4103/0970-1591.117287</ext-link></comment> <object-id pub-id-type="pmid">24082447</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lallas</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Auge</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Raj</surname> <given-names>GV</given-names></name>, <name name-style="western"><surname>Santa-Cruz</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Madden</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Preminger</surname> <given-names>GM</given-names></name>. <article-title>Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement</article-title>. <source>J Endourol</source>. <year>2002</year>;<volume>16</volume>(<issue>8</issue>):<fpage>583</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/089277902320913288" xlink:type="simple">10.1089/089277902320913288</ext-link></comment> <object-id pub-id-type="pmid">12470467</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kaplan</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Lipkin</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Scales</surname> <given-names>CD</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Preminger</surname> <given-names>GM</given-names></name>. <article-title>Use of ureteral access sheaths in ureteroscopy</article-title>. <source>Nat Rev Urol</source>. <year>2016</year>;<volume>13</volume>(<issue>3</issue>):<fpage>135</fpage>–<lpage>40</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrurol.2015.271" xlink:type="simple">10.1038/nrurol.2015.271</ext-link></comment> <object-id pub-id-type="pmid">26597613</object-id></mixed-citation></ref>
<ref id="pone.0193600.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lildal</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Nørregaard</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Andreassen</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Christiansen</surname> <given-names>FE</given-names></name>, <name name-style="western"><surname>Jung</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>MR</given-names></name>, <etal>et al</etal>. <article-title>Ureteral Access Sheath Influence on the Ureteral Wall Evaluated by Cyclooxygenase-2 and Tumor Necrosis Factor-a in a Porcine Model</article-title>. <source>J Endourol</source>. <year>2017</year>;<volume>31</volume>(<issue>3</issue>):<fpage>307</fpage>–<lpage>313</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/end.2016.0773" xlink:type="simple">10.1089/end.2016.0773</ext-link></comment> <object-id pub-id-type="pmid">27998175</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>